Stay updated with breaking news from Maria Maccecchini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MALVERN, Pa., May 21, 2024 -- Annovis Bio, Inc. , a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced the publication of a new article...
The last few days have been very difficult. I received a lot of emails and phone calls that often expressed anger, uncertainty, and disappointment. Additionally, our results were questioned and...
Significantly higher rate of improvement in ADAS-Cog 11 scores in each treatment dose relative to placebo for patients with mild ADImprovement in cognition measured by ADAS-Cog 11 at three months is...
MALVERN, Pa., April 02, 2024 -- Annovis Bio, Inc. , a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, today provided a summary of corporate updates...
Further look at earlier Phase 1b study by ADCS unveils confirmatory data MALVERN, Pa., April 01, 2024 -- Annovis Bio, Inc. , a clinical-stage drug platform company developing novel therapies for...